TRPV1 channel mediated remote ischemic preconditioning signaling; implications for patients with and at risk for myocardial infarction​

College of Medicine – Phoenix, Basic Medical Sciences

When

Noon – 1 p.m., Oct. 9, 2025

WHERE

IN-PERSON: College of Medicine – Phoenix
Health Sciences Education Building, Room B202
435 N. Fifth St., Phoenix, AZ 85004

CME DETAILS AND LEARNING OBJECTIVES

CME credit provided by the University of Arizona College of Medicine – Tucson

Learning Objectives

  1. Understand the mechanisms underlying RIPC​
  2. Understand the limitations of bringing RIPC to the bedside​
  3. Recognize the role of TRPV1 channels in mediating the RIPC response​
  4. Explain how stimulating TRPV1 may result in clinical application of RIPC in patients​

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Arizona College of Medicine – Tucson and the University of Arizona College of Medicine – Phoenix The University of Arizona College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine – Tucson designates this live activity for a maximum of 1 AMA PRA Category 1 credit.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Relevant Financial Relationships Statement(s):

University of Arizona College of Medicine – Tucson Continuing Medical Education adheres to the Accreditation Council for Continuing Medical Education's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others, are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Name of individuals, role in activity, nature of relationship(s), name of ineligible company 

Frederic Zenhausern, MBA, activity director, nothing to disclose, 02/25/2025 

Jack Rubinstein, MD, faculty, nothing to disclose, 10/02/2025 

 PRESENTER DETAILS

Jack Rubinstein, MD, Professor, Internal Medicine
Cincinnati College of Medicine

 

 

 

 

 

 

Attachments